浸润性导管癌腋窝淋巴结术前MRI评估:基于Ki-67与受体状态的Luminal A与Luminal B亚型比较
本研究纳入125例术前接受乳腺MRI的浸润性导管癌患者,按Ki-67与受体状态分为Luminal A型(80例)和Luminal B型(45例)。Luminal B型病理证实腋窝淋巴结转移率显著高于Luminal A型(40.0% vs 13.8%,p<0.01),且MRI评估腋窝的阳性预测值在Luminal B型显著更高(76.2% vs 28.0%,p=0.004),阴性预测值两型无差异。
要点
- Luminal B型腋窝淋巴结转移率40.0%,高于Luminal A型的13.8%(p<0.01)。
- MRI评估腋窝阳性预测值Luminal B型76.2%,高于Luminal A型28.0%(p=0.004)。
- 两型MRI评估腋窝的阴性预测值无差异。
核心结论
- 使用包含Ki-67增殖指数的分子亚型分类时,MRI在Luminal B型肿瘤中检出的可疑淋巴结很可能有阳性发现,值得术前组织取样;而Luminal A型MRI可疑淋巴结假阳性率高,作者建议除高度可疑者外直接行前哨淋巴结活检。
研究设计与样本
- 研究纳入了2012年1月至2014年8月间接受术前乳腺MRI评估、可分类为Luminal A或Luminal B分子亚型的125例患者,亚型基于结合受体状态与Ki-67增殖指数的免疫组化替代指标分类,统计分析采用卡方检验和单因素方差分析,并对有统计学显著差异者以Bonferroni校正进行两两比较,另用多变量logistic回归分析判断分子亚型是否为淋巴结受累的独立预测因素。
诊断标准与关键数值
- Luminal B型病理证实腋窝淋巴结病变18/45(40.0%),Luminal A型11/80(13.8%),p<0.01。
- 控制患者年龄、肿瘤大小和肿瘤分级后,Luminal B型发生病理证实腋窝淋巴结病变的可能性是Luminal A型的4.3倍(p<0.01)。
- MRI评估腋窝的阳性预测值Luminal B型76.2% vs Luminal A型28.0%(p=0.004)。
- MRI评估腋窝的阴性预测值在Luminal A型与Luminal B型之间无差异。
临床应用与阅片要点
- 作者认为,MRI在Luminal B型肿瘤中检出的可疑淋巴结很可能有阳性发现,值得术前组织取样。
- 作者建议,鉴于Luminal A型MRI可疑淋巴结假阳性率高,除高度可疑发现者外,所有病例直接行前哨淋巴结活检。
局限性
- 作者指出这些结果应在更大规模的前瞻性研究中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to assess whether luminal A versus luminal B molecular subtypes of breast cancer affect the diagnostic utility of preoperative MRI evaluation of the axilla.
MATERIALS AND METHODS: This study identified 125 patients who underwent preoperative breast MRI evaluation of tumors classifiable as luminal A or luminal B molecular subtypes between January 2012 and August 2014. The subtypes were classified on the basis of immunohistochemical staining surrogates combining receptor status and the Ki-67 proliferation index. Statistical analysis was performed using chi-square analysis and one-way ANOVA. When a statistically significant difference was found, follow-up analysis involving pairwise comparison using the Bonferroni correction was performed. Multivariate logistic regression analysis was also used to determine whether the molecular subtype was independently predictive of lymph node involvement.
RESULTS: A total of 80 patients had tumors classifiable as the luminal A molecular subtype, whereas 45 patients had tumors classifiable as the luminal B subtype. Pathologically proven axillary lymph node (ALN) disease occurred statistically significantly more frequently in luminal B tumors (18/45 [40.0%]) than in luminal A tumors (11/80 [13.8%]; p < 0.01). In addition, pathologically proven ALN disease was 4.3 times more likely to occur in luminal B tumors after controlling for patient age, tumor size, and tumor grade (p < 0.01). We found no difference in the negative predictive value of the MRI assessment of the axilla when luminal A tumors were compared with luminal B tumors. The positive predictive value of MRI evaluation of ALNs is statistically significantly higher for luminal B tumors than for luminal A tumors (76.2% vs 28.0%, respectively; p = 0.004).
CONCLUSION: With the use of molecular subtype classification including the Ki-67 proliferation index, suspicious nodes detected in luminal B tumors by MRI are likely to have positive findings and warrant preoperative tissue sampling. Conversely, in view of the high false-positive rate of suspicious nodes detected in luminal A tumors by MRI, proceeding straight to sentinel lymph node biopsy for all cases, except for those with highly suspicious findings, is suggested. These results should, however, be validated in a larger prospective study.
引用
- Plaza MJ, Handa P, Esserman LE, et al. Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A Versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status. AJR Am J Roentgenol. 2017. PMID: 28140614. doi:10.2214/AJR.15.15788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。